The Australian Competition andConsumer Commission has said it is “urgently investigating” what it calls a a completed acquisition of pathology assets by Primary Health Care on Tuesday. This is after healthcare giant Healthscope has quietly walked away from its struggling Queensland pathology operations.
“QML is one of Australia’s oldest and most respected pathology providers,” she said. “We have been serving Queensland and northern NSW for nearly 100 years.” Said a spokeswoman for QML on Tuesday.
Full Content: Sydney Morning Herald
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
On Witness Stand, Google CEO Challenges DOJ’s Proposed Remedies In Search Monopoly Case
Apr 30, 2025 by
CPI
Latham & Watkins Expands German Antitrust Practice
Apr 30, 2025 by
CPI
DoorDash, Grubhub, and Uber Eats Settle With NYC Over Cap Fees
Apr 30, 2025 by
CPI
Pork Giants Push to Overturn Price-Fixing Suit Citing Clerk’s Alleged Conflicts
Apr 30, 2025 by
CPI
Novartis to Acquire Regulus Therapeutics in $1.7 Billion Deal
Apr 30, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece